Drug intelligence / Profile preview

xiongdan niuhuang

Development stage
Unknown
Lead developer
Hunan Jiudian Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

Xiongdan Niuhuang is a Traditional Chinese Medicine (TCM) combination therapy, most notably produced as an oropharyngeal spray by Hunan Jiudian Pharmaceutical. It is composed of bear bile powder (Xiongdan) and calculus bovis (Niuhuang). The drug is indicated for the treatment of acute upper respiratory tract infections, specifically for relieving symptoms such as sore throat, swelling, and cough associated with wind-heat syndrome. The pharmacological action is primarily attributed to the high concentration of bile acids, such as ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid (TUDCA), which exhibit significant anti-inflammatory, antimicrobial, and antipyretic activities. It is typically administered as a spray to provide localized relief to the throat while also exerting systemic anti-inflammatory effects through mucosal absorption.

Brand names
Xiongdan Niuhuang Penwu Ji
Other names
Bear Bile and Calculus Bovis Spray
02

Targets

VDR (Vitamin D receptor)SLC10A2 (Solute carrier family 10 member 2)NTCP (Na+-taurocholate cotransporting polypeptide)GPBAR1PXR (Pregnane X receptor)FXR (Farnesoid x-activated receptor)

Beyond the preview

Go deeper on xiongdan niuhuang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiongdan niuhuang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call